InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,018.39
(
-0.34%
)
US TECH 100
16,954.40
(
-0.17%
)
Dow Jones
37,903.29
(
0.23%
)
Brent Oil
83.87
(
0.40%
)
Bitcoin
57,489.53
(
-1.28%
)
Post# of 251670
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 827
Posts 119535
Boards Moderated 15
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 240835

Thursday, 06/29/2023 7:24:53 AM

Thursday, June 29, 2023 7:24:53 AM

Post# of 251670
LLY acquires SGTX for $14.92/sh cash +CVR potentially_worth_$111.64 (not a typo):

https://investor.lilly.com/news-releases/news-release-details/lilly-acquire-sigilon-therapeutics

The buyout price, excluding the CVR, is a 280% premium to yesterday’s closing price, but it is a 17% discount to SGTX’s IPO price in Dec 2020 (#msg-159908787). SGTX’s share price had fallen 95% from its IPO price in late 2021, when it announced a 40% layoff (#msg-167109942).

In pre-market trading today, SGTX is up six-fold due to investors’ assessment of the CVR.

The nominal deal value, excluding the SVR is $35M, but it could reach $310M if the CVR pays out in full.

LLY is already an 8.5% shareholder in SGTX, pursuant to partnership the companies inked in 2018 to develop a cell therapy for T1D.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up